Precise Determination of Time to Reach Viral Load Set Point After Acute HIV-1 Infection

被引:28
作者
Huang, Xiaojie
Chen, Hui [2 ]
Li, Wei
Li, Haiying
Jin, Xia [3 ]
Perelson, Alan S. [4 ]
Fox, Zoe [5 ]
Zhang, Tong
Xu, Xiaoning
Wu, Hao [1 ]
机构
[1] Capital Med Univ, Beijing YouAn Hosp, Ctr Infect Dis, Dept Infect Dis, Beijing 100069, Peoples R China
[2] Capital Med Univ, Dept Infect Dis, Beijing 100069, Peoples R China
[3] Univ Rochester, Med Ctr, Dept Infect Dis, Rochester, NY 14642 USA
[4] Los Alamos Natl Lab, Dept Infect Dis, Los Alamos, NM USA
[5] UCL, Sch Med, Dept Infect Dis, London W1N 8AA, England
基金
美国国家卫生研究院;
关键词
HIV-1; viral load; set point; acute infection; seroconversion; RNA LEVELS; NATURAL-HISTORY; HOMOSEXUAL-MEN; SEROCONVERSION; AIDS; MARKERS; COHORT; CD4; LYMPHOCYTES; PHENOTYPE;
D O I
10.1097/QAI.0b013e31827146e0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: The HIV viral load set point has long been used as a prognostic marker of disease progression and more recently as an end-point parameter in HIV vaccine clinical trials. The definition of set point, however, is variable. Moreover, the earliest time at which the set point is reached after the onset of infection has never been clearly defined. Methods: In this study, we obtained sequential plasma viral load data from 60 acutely HIV-infected Chinese patients among a cohort of men who have sex with men, mathematically determined viral load set point levels, and estimated time to attain set point after infection. We also compared the results derived from our models and that obtained from an empirical method. Results: With novel uncomplicated mathematic model, we discovered that set points may vary from 21 to 119 days dependent on the patients' initial viral load trajectory. The viral load set points were 4.28 +/- 0.86 and 4.25 +/- 0.87 log10 copies per milliliter (P = 0.08), respectively, as determined by our model and an empirical method, suggesting an excellent agreement between the old and new methods. Conclusions: We provide a novel method to estimate viral load set point at the very early stage of HIV infection. Application of this model can accurately and reliably determine the set point, thus providing a new tool for physicians to better monitor early intervention strategies in acutely infected patients and scientists to rationally design preventative vaccine studies.
引用
收藏
页码:448 / 454
页数:7
相关论文
共 29 条
[1]  
Achhra Amit C, 2010, J AIDS Clin Res, V1, P1
[2]   Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1 [J].
Benlahrech, Adel ;
Harris, Julian ;
Meiser, Andrea ;
Papagatsias, Timos ;
Hornig, Julia ;
Hayes, Peter ;
Lieber, Andre ;
Athanasopoulos, Takis ;
Bachy, Veronique ;
Csomor, Eszter ;
Daniels, Rod ;
Fisher, Kerry ;
Gotch, Frances ;
Seymour, Len ;
Logan, Karen ;
Barbagallo, Romina ;
Klavinskis, Linda ;
Dickson, George ;
Patterson, Steven .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (47) :19940-19945
[3]  
Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204
[4]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[5]  
BOFILL M, 1992, CLIN EXP IMMUNOL, V88, P243, DOI 10.1111/j.1365-2249.1992.tb03068.x
[6]   Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial [J].
Buchbinder, Susan P. ;
Mehrotra, Devon V. ;
Duerr, Ann ;
Fitzgerald, Daniel W. ;
Mogg, Robin ;
Li, David ;
Gilbert, Peter B. ;
Lama, Javier R. ;
Marmor, Michael ;
del Rio, Carlos ;
McElrath, M. Juliana ;
Casimiro, Danilo R. ;
Gottesdiener, Keith M. ;
Chodakewitz, Jeffrey A. ;
Corey, Lawrence ;
Robertson, Michael N. .
LANCET, 2008, 372 (9653) :1881-1893
[7]   Establishment of adult peripheral blood lymphocyte subset reference range for an Asian population by single-platform flow cytometry: Influence of age, sex, and race and comparison with other published studies [J].
Chng, WJ ;
Tan, GB ;
Kuperan, P .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2004, 11 (01) :168-173
[8]   Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion [J].
Farzadegan, H ;
Henrard, DR ;
Kleeberger, CA ;
Schrager, L ;
Kirby, AJ ;
Saah, AJ ;
Rinaldo, CR ;
OGorman, M ;
Detels, R ;
Taylor, E ;
Phair, JP ;
Margolick, JB .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 13 (05) :448-455
[9]   A whole-genome association study of major determinants for host control of HIV-1 [J].
Fellay, Jacques ;
Shianna, Kevin V. ;
Ge, Dongliang ;
Colombo, Sara ;
Ledergerber, Bruno ;
Weale, Mike ;
Zhang, Kunlin ;
Gumbs, Curtis ;
Castagna, Antonella ;
Cossarizza, Andrea ;
Cozzi-Lepri, Alessandro ;
De Luca, Andrea ;
Easterbrook, Philippa ;
Francioli, Patrick ;
Mallal, Simon ;
Martinez-Picado, Javier ;
Miro, Jose M. ;
Obel, Niels ;
Smith, Jason P. ;
Wyniger, Josiane ;
Descombes, Patrick ;
Antonarakis, Stylianos E. ;
Letvin, Norman L. ;
McMichael, Andrew J. ;
Haynes, Barton F. ;
Telenti, Amalio ;
Goldstein, David B. .
SCIENCE, 2007, 317 (5840) :944-947
[10]   Prediction of residual time to AIDS and death based on markers and cofactors [J].
Geskus, RB ;
Miedema, FA ;
Goudsmit, J ;
Reiss, P ;
Schuitemaker, H ;
Coutinho, RA .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 32 (05) :514-521